|
|
| Literature on Type 2 Diabetes |
| |
- Bener A, Zirie M, Al-Rikabi A. Genetics, obesity, and environmental risk factors associated with type 2 diabetes. Croat Med J. 46(2):302-307 (2005).
- Das, S.K. and Elbein, S.C. The Genetic Basis of Type 2 Diabetes. Cellscience, 2(4): 100–131 (2006).
- Hales,C. The Pathogenesis of NIDDM. Diabetologia, 37, S162-S168 (1994).
- Hansen,T. Genetics of Type 2 diabetes.Curr. Sci., 83, 1477-1482 (2002).
- Hara K, Yamauchi T, Kadowaki T. An adipokine linking adipocytes and type 2 diabetes in humans. Curr Diab Rep. 5(2):136-140 (2005).
- Kahn, S.E., Hull, R.L. and Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444, 840-846 (2006).
- Lowell, B.B. and Shulman, G.Ie Mitochondrial Dysfunction and Type 2 Diabetes. Science, 307, 384-387 (2005).
- Mahler, R.J. and Adler, M.L. Type 2 Diabetes Mellitus: Update on Diagnosis, Pathophysiology, and Treatment. JCE & M., 84, 1165-1171 (1999).
- Nazimek-Siewniak B, Moczulski D, Grzeszczak W. Risk of macrovascular and microvascular complications in Type 2 diabetes Results of longitudinal study design. Journal of Diabetes and its Complications.16(4):271-276 (2002).
- Ozcan U, Cao Q, Yilmaz E, Lee A.H., Iwakoshi N.N., Ozdelen E, Tuncman G, Gorgun C, Glimcher L.H., Hotamisligil G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science.306, 457–461 (2004).
- Rhodes, C.J. and White, M.F.Molecular insights into insulin action and secretion.Eur J Clin Invest 32, Suppl 3: 3–13 (2002).
- Shuldiner, A.R. and McLenithan, J.C.Genes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again. J. Clin. Invest. 114:1414–1417 (2004).
- Steinberger, J., Daniels, S.R.Obesity, Insulin Resistance, Diabetes, and Cardiovascular Risk in Children. Circulation, 107, 1448-1453 (2003).
- Ward, W.K., Beard, J.C., Porte D.Clinical aspects of islet B cell function in non-insulin dependent diabetes mellitus. Diabetes Metab Rev. 2:297–313 (1986)
- Weir, G.C. and Bonner Weir, S.Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes, 53, S16–S21 (2004).
- World Health Organization. Diabetes Mellitus:Report of a WHO Study Group. Geneva:WHO, 1985. Technical Report Series 727
|
|
|